Piramal Pharma informs about disclosure

12 Sep 2023 Evaluate

In accordance with the provisions of Regulation 30 of the SEBI Listing Regulations, Piramal Pharma has informed that pursuant to an intimation received from Legal Affairs Bureau, Tokyo (the ‘Authority’) on September 12, 2023, voluntary liquidation of Piramal Pharma Japan GK, a step-down wholly - owned subsidiary of the Company has been approved by the Authority. The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are given under Annexure A.

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

174.20 0.00 (0.00%)
29-Dec-2025 10:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.40
Dr. Reddys Lab 1266.45
Cipla 1505.95
Zydus Lifesciences 907.65
Lupin 2101.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×